Healthcare provider profile · identity verified

Lisa Abdul-Haqq, CRNP

Nurse Practitioner · PHILADELPHIA, PA · NPI 1982369708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	677	212
Amlodipine Besylate	Amlodipine Besylate	408	136
Albuterol Sulfate Hfa	Albuterol Sulfate	389	140
Metformin Hcl	Metformin Hcl	282	91
Omeprazole	Omeprazole	277	94
Gabapentin	Gabapentin	276	88
Lisinopril	Lisinopril	253	82
Fluticasone Propionate	Fluticasone Propionate	245	115
Losartan Potassium	Losartan Potassium	243	87
Rosuvastatin Calcium	Rosuvastatin Calcium	206	65
Metoprolol Succinate	Metoprolol Succinate	203	71
Carvedilol	Carvedilol	183	65
Levothyroxine Sodium	Levothyroxine Sodium	172	54
Furosemide	Furosemide	162	61
Naproxen	Naproxen	160	88
Tramadol Hcl	Tramadol Hcl	160	61
Pantoprazole Sodium	Pantoprazole Sodium	149	55
Trulicity	Dulaglutide	142	20
Glimepiride	Glimepiride	141	38
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	138	44
Methylprednisolone	Methylprednisolone	129	102
Eliquis	Apixaban	97	31
Trazodone Hcl	Trazodone Hcl	94	35
Tamsulosin Hcl	Tamsulosin Hcl	92	36
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	91	25
Alendronate Sodium	Alendronate Sodium	86	32
Diclofenac Sodium	Diclofenac Sodium	82	52
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	28
Metoprolol Tartrate	Metoprolol Tartrate	78	27
Hydrochlorothiazide	Hydrochlorothiazide	73	24
Famotidine	Famotidine	72	28
Azithromycin	Azithromycin	71	67
Ozempic	Semaglutide	70	15
Mirtazapine	Mirtazapine	69	28
Clopidogrel	Clopidogrel Bisulfate	68	25
Ibuprofen	Ibuprofen	68	38
Hydralazine Hcl	Hydralazine Hcl	65	20
Prednisone	Prednisone	64	48
Citalopram Hbr	Citalopram Hydrobromide	63	22
Duloxetine Hcl	Duloxetine Hcl	61	20
Glipizide	Glipizide	59	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	58	27
Montelukast Sodium	Montelukast Sodium	58	20
Simvastatin	Simvastatin	54	18
Triamcinolone Acetonide	Triamcinolone Acetonide	54	42
Sertraline Hcl	Sertraline Hcl	53	19
Allopurinol	Allopurinol	52	19
Diazepam	Diazepam	51	16
Tradjenta	Linagliptin	51	suppressed
Alprazolam	Alprazolam	50	suppressed
Breo Ellipta	Fluticasone/Vilanterol	50	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	28
Escitalopram Oxalate	Escitalopram Oxalate	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	17
Nifedipine Er	Nifedipine	44	20
Myrbetriq	Mirabegron	42	11
Sumatriptan Succinate	Sumatriptan Succinate	41	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	36
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	11
Oxybutynin Chloride	Oxybutynin Chloride	37	14
Clonidine Hcl	Clonidine Hcl	35	suppressed
Januvia	Sitagliptin Phosphate	35	11
Tizanidine Hcl	Tizanidine Hcl	35	17
Oxycodone Hcl	Oxycodone Hcl	34	12
Lorazepam	Lorazepam	33	11
Buspirone Hcl	Buspirone Hcl	32	suppressed
Glipizide Er	Glipizide	32	suppressed
Atenolol	Atenolol	31	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Ezetimibe	Ezetimibe	31	11
Aripiprazole	Aripiprazole	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	17
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	26
Donepezil Hcl	Donepezil Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	14
Baclofen	Baclofen	26	suppressed
Labetalol Hcl	Labetalol Hcl	26	suppressed
Doxepin Hcl	Doxepin Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Valsartan	Valsartan	25	suppressed
Bumetanide	Bumetanide	24	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	20
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Ketoconazole	Ketoconazole	22	15
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Nystatin	Nystatin	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Topiramate	Topiramate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Ofloxacin	Ofloxacin	21	20
Spironolactone	Spironolactone	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Methimazole	Methimazole	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	17	17
Fenofibrate	Fenofibrate	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Cephalexin	Cephalexin	15	15
Estradiol	Estradiol	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	11
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Klayesta	Nystatin	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	13
Sucralfate	Sucralfate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin	Amoxicillin	12	12
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error